Immune-mediated inflammatory disease

Disease

3 papers4 findings

  • Humans3

Effects

3

Myocardial infarction

upin humans1

1 study
  1. Immune-mediated inflammatory disease increases myocardial infarction in humans (12.9 vs. 8.6 per 1000 person-years).

    “greater incidence of MI/revascularization (12.9 vs. 8.6 per 1000 person-years) than matched controls (n = 2190)”

    Humanscompared to matched controlsn = 1,095

    Spatial- and attenuation-based epicardial adipose tissue features on CT calcium-score exams predict ASCVD events in immune-mediated inflammatory diseases

    AHA Scientific Sessions 2025 abstract3 Nov 2025

More on Myocardial infarction

Epicardial adipose tissue volume

upin humans1

1 study
  1. Immune-mediated inflammatory disease increases epicardial adipose tissue volume in humans (p<0.005).

    “IMID patients (N=1095, SLE: 162, RA: 557, Psoriasis: 430) had significantly higher EAT volume (p<0.005)”

    Humanscompared to matched controlsn = 1,095

    Spatial- and attenuation-based epicardial adipose tissue features on CT calcium-score exams predict ASCVD events in immune-mediated inflammatory diseases

    AHA Scientific Sessions 2025 abstract3 Nov 2025

More on Epicardial adipose tissue volume

Senescent CD8+ T cells

upin humans1

1 study
  1. Immune-mediated inflammatory disease increases senescent CD8+ T cells in humans.

    “T8sen, but not T4sen, accumulated more in patients with IMIDs than in patients with lung cancer and healthy donors.”

    Humansin IMID patients compared to lung cancer patients and healthy donors

    Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokines

    Clinical and experimental immunology21 Jan 2025

More on Senescent CD8+ T cells

Associations

1

Incident myocardial infarction or coronary revascularization

upin humans1

1 study
  1. Immune-mediated inflammatory disease raises the risk of incident myocardial infarction or coronary revascularization in humans (six-fold higher (7.13 vs 1.12 per 1000 person-years)).

    “Among patients with no coronary calcium, IMID patients experienced a six-fold higher event rate than controls (7.13 vs 1.12 per 1000 person-years).”

    Humansin patients with zero CAC

    Coronary Artery Calcium and Risk of Cardiovascular Events in Immune-Mediated Inflammatory Disease from the CLARIFY No/Low-Cost CT Calcium Score Registry

    AHA Scientific Sessions 2025 abstract3 Nov 2025

More on Incident myocardial infarction or coronary revascularization

Trial sponsors

  • Bayer

    Company1 trialPhase 151 people

Latest

Nov 2025: 2Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 03 in 12 months